Showing results (471-480 of 537) with videos related to
Sort By:
Pageof 54
The Journal of Rheumatology|April 2, 2022
Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) MeetingCarmel Stober, Iain B McInnes, Soumya Raychaudhuri, et al.Annals of the Rheumatic Diseases|September 24, 2009
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisM J L Peters, D P M Symmons, D McCarey, et al.RMD Open|April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritisLeher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.Annals of the Rheumatic Diseases|August 16, 2015
MICL controls inflammation in rheumatoid arthritisPierre Redelinghuys, Lauren Whitehead, Andrea Augello, et al.Annals of the Rheumatic Diseases|September 9, 2018
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international surveyNadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, et al.The Journal of Allergy and Clinical Immunology|October 18, 2016
The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosisMariola Kurowska-Stolarska, Manhl K Hasoo, David J Welsh, et al.Annals of the Rheumatic Diseases|September 11, 2023
Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3)Peter C Taylor, Michael E Weinblatt, Iain B McInnes, et al.Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.BMJ Open|April 9, 2025
Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine studyFiona Rayner, Shaun Hiu, Andrew Melville, et al.Journal of Autoimmunity|April 18, 2025
Human regulatory B cells suppress autoimmune disease primarily via interleukin-37Luman Wang, Maria-Ioanna Christodoulou, Zheng Jin, et al.Pageof 54